Do you want to read an article? Please log in or register.
Implications of new obesity definitions in the classification and outcomes of patients with MASLD
Further Publications
Related content
HepatitisHepatology
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported Outcomes
J Gastroenterol Hepatol
Papatheodoridis G, Buti M, Yilmaz Y, Yu ML, El-Kassas M, Alswat K, Fernandez MIC, Eguchi Y, Duseja A, Keklikkiran C, Hamid S, Chan WK, Gordon SC, Roberts SK, George J, Singal AK, Ahmed A, Lam B, Nader F, Henry L, Stepanova M, Alqahtani SA, Younossi ZM
doi: 10.1111/jgh.70533
Inflammatory Bowel Disease
Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis
Inflamm Bowel Dis
Desai A, Habib H, Khataniar H, Farraye FA, Sehgal P, Barnes EL, Kochhar GS, Hashash JG
doi: 10.1093/ibd/izaf301
Inflammatory Bowel Disease
Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City
Inflamm Bowel Dis
Klein S, Sivasailam B, Alizadeh M, Malter L, Axelrad JE
doi: 10.1093/ibd/izaf174
Gastrointestinal Cancer
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort
J Clin Oncol
Moon AM, Yanagihara TK, Dawson LA, Yu JI, Lawrence TS, Kim TH, Yan M, Iwata H, Nabavizadeh N, Apisarnthanarax S, Dunne EM, Lock MI, Chuong MD, Chiang CL, Scorsetti M, Katoh N, Sioshansi S, Numata K, Liu HY, Iwamoto H, Wakatsuki M, Chen Y, Pollom EL, Gkika E, Jabbour SK, Munoz-Schuffenegger P, Dutta D, Hajj C, Ueno M, Hallemeier CL, Feldman AM, Méndèz Romero A, Tan X, Molla M, Tepper JE, Torres F, Reig M, EBRT Collaboration Group
doi: 10.1200/JCO-25-02399
Hepatology
Association between longitudinal weight change and clinical outcome in individuals with MASLD
Hepatology
Shi Y, Zhou R, Kim SU, Yip TC, Tsochatzis E, Petta S, Nakajima A, Hagström H, Bugianesi E, Chan WK, Boursier J, Goh BG, Sanyal AJ, Romero-Gomez M, Calleja JL, Lédinghen V, Newsome PN, Fan JG, Lai M, Castéra L, Fournier-Poizat C, Lee HW, Wong GL, Pennisi G, Yoneda M, Shang Y, Armandi A, de Saint-Loup M, Canivet CM, Teh KK, Asgharpour A, Gallego-Durán R, Llop E, Lara-Romero C, Sau-Wai Chan M, Zoncape M, Lin H, Liu WY, Targher G, Byrne CD, Wong VW, Zheng MH, VCTE-Prognosis Study Group
doi: 10.1097/HEP.0000000000001557
Colonoscopy
Pediatric Versus Adult Colonoscopes Effectiveness in Obese Patients: The PACE Randomized Clinical Trial
Am J Gastroenterol
Ahmad AI, Ansari Z, Al-Din TJ, Nicolas MA, Restrepo D, Almomani A, Zahid E, Gonzalez A, Klein D, Jimenez B, Castro F, Rahman AU
doi: 10.14309/ajg.0000000000004027
COMMENTED
Further Publications
GLP-1 receptor agonist-SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Hepatology
Mao X, Fan H, Yuen MF, Cheung R, Seto WK, Nguyen MH
doi: 10.1097/HEP.0000000000001771
Further Publications
Moderate alcohol consumption and clinical outcomes in MASLD: a systematic review and meta-analysis of longitudinal cohorts
BMC Gastroenterol
de Souza NS, Cotrim HP, de Andrade ARCF
doi: 10.1186/s12876-026-04814-5
Further Publications
Evaluating the 2023 EASL guidelines for intrahepatic cholestasis of pregnancy: risk stratification and outcomes in over 4,000 U.S. patients
Am J Gastroenterol
Rodriguez N, Katzenstein C, Alpert L, Sigel K, Sperling RS, Williamson C, Kushner T
doi: 10.14309/ajg.0000000000003866